Family Office of America, Inc. (FOFA): Total Liabilities

Annual figures by period end, from SEC filings.

$878.5K
As of 2025-12-31
$1.65M
As of 2026-06-30
+130.7%
3-year compound annual growth
2021-12-31: $29.6K2022-12-31: $71.5K2023-12-31: $525.4K2024-12-31: $44.0K2025-12-31: $878.5K$878.5K
2021-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$878.5Kn/m2026-04-16, Balance as of period end
2024-12-31$44.0K-91.6%2026-04-16, Balance as of period end
2023-12-31$525.4K+634.7%2025-03-10, Balance as of period end
2022-12-31$71.5K+141.2%2024-07-18, Balance as of period end
2021-12-31$29.6Kn/a2023-04-24, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Family Office of America, Inc. (FOFA)2025-12-31$878.5Kn/m
Pulse Biosciences, Inc. (PLSE)2025-12-31$13.88M-21.1%
Co-Diagnostics, Inc. (CODX)2025-12-31$4.11M-57.5%
Harvard Apparatus Regenerative Technology, Inc. (HRGN)2025-12-31$1.62M+32.8%
Vivos Inc (RDGL)2025-12-31$206.7K+139.8%
Catheter Precision, Inc. (VTAK)2025-12-31$9.21M-42.5%
Sintx Technologies, Inc. (SINT)2025-12-31$6.58M+19.2%
RenovoRx, Inc. (RNXT)2025-12-31$2.67M-26.6%
PetVivo Holdings, Inc. (PETV)2026-03-31$1.38M-73.1%

Compare FOFA, PLSE, CODX, HRGN side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗